Sotera Health Company $SHC Stock Position Raised by Charles Schwab Investment Management Inc.

Key Points

• Charles Schwab Investment Management Inc. increased its stake in Sotera Health Company by 5.1% in the first quarter, owning approximately 1,415,282 shares worth $16.5 million.
• Sotera Health reported $0.20 earnings per share (EPS) for the last quarter, surpassing expectations and showing a year-over-year revenue growth of 6.4%.
• Goldman Sachs upgraded Sotera Health's rating from "neutral" to "buy," with an increased target price from $14.00 to $17.00.

Charles Schwab Investment Management Inc. increased its holdings in shares of Sotera Health Company (NASDAQ:SHC - Free Report) by 5.1% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,415,282 shares of the company's stock after purchasing an additional 68,087 shares during the period. Charles Schwab Investment Management Inc. owned 0.50% of Sotera Health worth $16,502,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the stock. Bank of Montreal Can lifted its stake in shares of Sotera Health by 10.6% during the fourth quarter. Bank of Montreal Can now owns 18,184 shares of the company's stock worth $249,000 after purchasing an additional 1,740 shares in the last quarter. Canada Pension Plan Investment Board grew its stake in shares of Sotera Health by 53.0% in the fourth quarter. Canada Pension Plan Investment Board now owns 15,300 shares of the company's stock valued at $209,000 after buying an additional 5,300 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Sotera Health by 27.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,143,955 shares of the company's stock valued at $43,004,000 after buying an additional 673,979 shares during the period. MetLife Investment Management LLC lifted its position in Sotera Health by 9.1% during the 4th quarter. MetLife Investment Management LLC now owns 86,177 shares of the company's stock worth $1,179,000 after acquiring an additional 7,174 shares in the last quarter. Finally, Tower Research Capital LLC TRC lifted its position in Sotera Health by 37.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company's stock worth $82,000 after acquiring an additional 1,640 shares in the last quarter. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on SHC shares. Wall Street Zen raised shares of Sotera Health from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 16th. Barclays reaffirmed an "overweight" rating on shares of Sotera Health in a report on Friday, August 8th. Finally, The Goldman Sachs Group upgraded shares of Sotera Health from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $14.00 to $17.00 in a report on Monday, May 5th. Four analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $16.00.

Sotera Health Stock Up 0.1%

Shares of SHC traded up $0.01 during midday trading on Tuesday, hitting $16.40. The company had a trading volume of 1,513,353 shares, compared to its average volume of 1,244,798. The stock has a market cap of $4.66 billion, a price-to-earnings ratio of 205.03 and a beta of 1.81. The company's 50 day moving average price is $12.45 and its 200 day moving average price is $12.17. The company has a quick ratio of 2.23, a current ratio of 2.47 and a debt-to-equity ratio of 4.49. Sotera Health Company has a 52 week low of $9.53 and a 52 week high of $17.08.

Sotera Health (NASDAQ:SHC - Get Free Report) last posted its quarterly earnings results on Friday, August 8th. The company reported $0.20 EPS for the quarter, topping analysts' consensus estimates of $0.17 by $0.03. Sotera Health had a return on equity of 39.42% and a net margin of 2.14%.The business had revenue of $294.34 million during the quarter, compared to the consensus estimate of $275.81 million. During the same period last year, the firm earned $0.19 earnings per share. The company's revenue for the quarter was up 6.4% compared to the same quarter last year. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. On average, equities research analysts predict that Sotera Health Company will post 0.61 EPS for the current year.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.